Skip to main content

Month: June 2023

Nokia Corporation: Repurchase of own shares on 14.06.2023

Nokia CorporationStock Exchange Release14 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 14.06.2023 Espoo, Finland – On 14 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 317,460 3.88CEUX 33,860 3.87AQEU 1,740 3.89TQEX 9,940 3.88Total 363,000 3.88* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

ERYTECH announces that the Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma

ERYTECH announces that the Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes PharmaCambridge, MA (U.S.) and Lyon (France), June 14, 2023, 8:00 pm CEST – ERYTECH Pharma (Nasdaq & Euronext: ERYP), announced today that the Lyon Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma. Erytech is pleased with today’s order delivered by the President of the Lyon Commercial Court. This order rejected Akkadian Partners’ attempt to postpone the vote on the merger. As a result, Erytech shareholders will be able to legitimately vote on the merger on June 23, 2023. An expert has been appointed to examine the merger parity and must submit his report to the parties within 4 months. Akkadian Partners has to cover the costs...

Continue reading

Ipsen announces U.S. FDA submission acceptance of its supplemental New Drug Application for Onivyde regimen in first-line metastatic pancreatic ductal adenocarcinoma

Supplemental New Drug Application (sNDA) submission based on the NAPOLI 3 Phase III trial1 Approval would represent expansion of treatment options in an aggressive and difficult-to-treat cancer with few treatment options currently availablePARIS, FRANCE, 14 June 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental new drug application (sNDA) Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) as a potential first-line treatment for metastatic pancreatic ductal adenocarcinoma (mPDAC). The review is based on positive results from the pivotal Phase III NAPOLI 3 trial, in which the Onivyde regimen demonstrated a statistically significant improvement in overall survival (OS) and progression-free survival...

Continue reading

Helexia secures a new 90-megawatt contract in Brazil

Helexia secures a new 90-megawatt contract in Brazil Helexia, a subsidiary of Voltalia (Euronext Paris, ISIN code: FR0011995588), has signed a contract with Comerc Energia, a leading provider of energy management solutions in Brazil. The agreement reached between Helexia and Comerc Energia provides the supply of up to 90 megawatts of photovoltaic energy over a 20-year period, distributed across a series of decentralised production projects. These will be built in the Brazilian states of Mato Grosso do Sul, Ceará and Pernambuco, strengthening Helexia’s presence in Brazil. Construction work on the first 11-megawatt projects will begin in the coming months, with commissioning scheduled for the first quarter of 2024. The other sites should start construction progressively shortly after the first sites, with the aim of exploiting the...

Continue reading

Rackspace Technology to Attend Texas Digital Government Summit 2023

SAN ANTONIO, June 14, 2023 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT) — a leading end-to-end, multicloud technology solutions company, today announced its participation in the Texas Digital Government Summit 2023, held on June 29 in Austin, Texas. The Texas Digital Government Summit is an annual event that brings together technology leaders from state and local government agencies and industry experts to share best practices, explore emerging trends, and discuss the challenges and opportunities facing the public sector in today’s digital age. As a trusted partner to many government agencies, Rackspace Technology is committed to helping organizations in Texas and beyond navigate the complexities of modern technology and deliver innovative solutions that improve citizen services and drive operational efficiency. “Our...

Continue reading

Crazy Woman Creek Bancorp Named to American Banker Magazine’s Top 200 Publicly Traded Community Banks List

BUFFALO, Wyo., June 14, 2023 (GLOBE NEWSWIRE) — Crazy Woman Creek Bancorp, Inc. (OTCPink: CRZY) parent company of Buffalo Federal Bank, today announced its inclusion in American Banker Magazine’s annual list of Top 200 Publicly Traded Community Banks and Thrifts under $2.0 billion in asset size. In its June 12, 2023 article, American Banker ranked Crazy Woman Creek Bancorp in the Top 200 Publicly Traded Community Banks and Thrifts list based on three-year average return on equity (“ROE”) as of 12/31/2022 (Source: Capital Performance Group). The rankings include publicly-traded banks and thrifts with less than $2 billion in assets. “American Banker is a highly respected industry publication and we are honored to have made their top 200 list,” stated Paul M. Brunkhorst, President and CEO. “Being listed in the Top 200 is a validation...

Continue reading

Correction: AUGA group, AB subsidiaries signed a share sale agreement of the Kooperatinė Bendrovė “Grybai LT” with Akcinė Bendrovė “Kauno grūdai”

AUGA group, AB supplemented the announcement with the calculation formula for the sale price of shares and other information. On 7 June 2023, AUGA group, AB subsidiaries Baltic Champs, UAB, UAB “AUGA Luganta“, Kooperatinė Bendrovė “AgroMilk“, Kooperatinė Bendrovė “Juodmargėlis“ and Kooperatinė Bendrovė „Šventosios pievos“ (hereinafter the Seller) have signed an agreement with AB Linas Agro Group controlled Akcinė Bendrovė Kauno Grūdai (hereinafter – the Buyer) concerning the sale of 100% of the shares of the Kooperatinė Bendrovė “Grybai LT“ (hereinafter the Company). Negotiations regarding sale of the shares of the Company were conducted on the basis of the letter of intent signed on 7 March 2023 between the Buyer and the main member of the Company Baltic Champs, UAB. The transaction will be completed only if the permission of the...

Continue reading

NABP Acquires Patient Safety Tool From Chronicled, Inc.

MOUNT PROSPECT, IL, June 14, 2023 (GLOBE NEWSWIRE) — The National Association of Boards of Pharmacy® (NABP®) announced today that it acquired the MediLedger Product Verification System (PVS) from Chronicled, Inc. The Association purchased the PVS to enable trading partners and regulators to conduct product verification, when required by the Drug Supply Chain Security Act (DSCSA), for use in its new product, Pulse by NABP™. Since launching the PVS in 2019, Chronicled has used its blockchain-powered MediLedger Network to make life sciences more accurate, efficient​,​ and aligned across the industry. The PVS has assisted members of the supply chain in complying with DSCSA, and it will continue to provide this assistance when Pulse launches this summer. Pulse is the Association’s inclusive, accessible​,​ and secure digital platform...

Continue reading

Vital Signs: Pulse Oximeter Market Shows Strong Vitality

SkyQuest’s Pulse Oximeters market report provides actionable insights for individuals interested in valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is produced and published concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford, USA, June 14, 2023 (GLOBE NEWSWIRE) — The global Pulse Oximeters market size is expected to reach USD 3.12 billion by 2030 and exhibit a CAGR of 7.7% in the forecast period (2022−2030), according to Skyquest’s latest research report. The growing prevalence of respiratory and cardiovascular diseases, the rising...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.